Kết quả tìm kiếm - Sorbye, Halfdan
- Đang hiển thị 1 - 20 kết quả của 32
- Chuyển đến trang tiếp theo
-
1
-
2
-
3
Duodenogastric Reflux Increases the Penetration of N‐(3)H‐Methyl‐N‐nitro‐N‐nitrosoguanidine into the Antral Mucosa of Rats: A Possible Role for Mucosal Erosions and Increased Cell... Bằng Øvrebø, Kjell K., Svanes, Knut, Aase, Steinar, Grong, Ketil, Sørbye, Halfdan
Được phát hành 2002Text -
4
Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours Bằng Sorbye, Halfdan, Meyer, Liv Sylvi, Mordal, Kjersti Elisabeth, Myhre, Simen, Thiis-Evensen, Espen
Được phát hành 2020Text -
5
Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy f... Bằng Winther, Stine Braendegaard, Österlund, Pia, Berglund, Åke, Glimelius, Bengt, Qvortrup, Camilla, Sorbye, Halfdan, Pfeiffer, Per
Được phát hành 2017Text -
6
-
7
Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases Bằng Løes, Inger Marie, Immervoll, Heike, Sorbye, Halfdan, Angelsen, Jon‐Helge, Horn, Arild, Knappskog, Stian, Lønning, Per Eystein
Được phát hành 2016Text -
8
-
9
High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer Bằng Siesing, Christina, Sorbye, Halfdan, Dragomir, Anca, Pfeiffer, Per, Qvortrup, Camilla, Pontén, Fredrik, Jirström, Karin, Glimelius, Bengt, Eberhard, Jakob
Được phát hành 2017Text -
10
CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup Bằng Aasebø, Kristine, Dragomir, Anca, Sundström, Magnus, Mezheyeuski, Artur, Edqvist, Per-Henrik, Eide, Geir Egil, Ponten, Fredrik, Pfeiffer, Per, Glimelius, Bengt, Sorbye, Halfdan
Được phát hành 2020Text -
11
High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Met... Bằng Sorbye, Halfdan, Dragomir, Anca, Sundström, Magnus, Pfeiffer, Per, Thunberg, Ulf, Bergfors, Monica, Aasebø, Kristine, Eide, Geir Egil, Ponten, Fredrik, Qvortrup, Camilla, Glimelius, Bengt
Được phát hành 2015Text -
12
Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre rando... Bằng Labori, Knut Jørgen, Lassen, Kristoffer, Hoem, Dag, Grønbech, Jon Erik, Søreide, Jon Arne, Mortensen, Kim, Smaaland, Rune, Sorbye, Halfdan, Verbeke, Caroline, Dueland, Svein
Được phát hành 2017Text -
13
Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients Bằng Aasebø, Kristine Ø., Dragomir, Anca, Sundström, Magnus, Mezheyeuski, Artur, Edqvist, Per‐Henrik, Eide, Geir Egil, Ponten, Fredrik, Pfeiffer, Per, Glimelius, Bengt, Sorbye, Halfdan
Được phát hành 2019Text -
14
Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients Bằng Aasebø, Kristine, Bruun, Jarle, Bergsland, Christian H., Nunes, Luís, Eide, Geir Egil, Pfeiffer, Per, Dahl, Olav, Glimelius, Bengt, Lothe, Ragnhild A., Sorbye, Halfdan
Được phát hành 2021Text -
15
Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study Bằng Tarpgaard, Line S., Guren, Tormod K., Glimelius, Bengt, Christensen, Ib J., Pfeiffer, Per, Kure, Elin H., Sorbye, Halfdan, Ikdahl, Tone, Yilmaz, Mette, Johansen, Julia S., Tveit, Kjell Magne
Được phát hành 2014Text -
16
Let-7 miRNA-binding site polymorphism in the KRAS 3(′)UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorecta... Bằng Kjersem, Janne B, Ikdahl, Tone, Guren, Tormod, Skovlund, Eva, Sorbye, Halfdan, Hamfjord, Julian, Pfeiffer, Per, Glimelius, Bengt, Kersten, Christian, Solvang, Hiroko, Tveit, Kjell M, Kure, Elin H
Được phát hành 2012Text -
17
Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer Bằng Thomsen, Maria, Kersten, Christian, Sorbye, Halfdan, Skovlund, Eva, Glimelius, Bengt, Pfeiffer, Per, Johansen, Julia S., Kure, Elin H., Ikdahl, Tone, Tveit, Kjell Magne, Christoffersen, Thoralf, Guren, Tormod Kyrre
Được phát hành 2016Text -
18
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome Bằng Thomsen, Maria, Skovlund, Eva, Sorbye, Halfdan, Bolstad, Nils, Nustad, Kjell Johannes, Glimelius, Bengt, Pfeiffer, Per, Kure, Elin H., Johansen, Julia S., Tveit, Kjell Magne, Christoffersen, Thoralf, Guren, Tormod Kyrre
Được phát hành 2018Text -
19
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3) Bằng Ali, Abir Salwa, Grönberg, Malin, Langer, Seppo W., Ladekarl, Morten, Hjortland, Geir Olav, Vestermark, Lene Weber, Österlund, Pia, Welin, Staffan, Grønbæk, Henning, Knigge, Ulrich, Sorbye, Halfdan, Janson, Eva Tiensuu
Được phát hành 2018Text -
20
Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study Bằng Guren, Tormod Kyrre, Thomsen, Maria, Kure, Elin H, Sorbye, Halfdan, Glimelius, Bengt, Pfeiffer, Per, Österlund, Pia, Sigurdsson, Fridbjörn, Lothe, Inger Marie Bowitz, Dalsgaard, Astrid Marie, Skovlund, Eva, Christoffersen, Thoralf, Tveit, Kjell Magne
Được phát hành 2017Text